You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vascular endothelial growth factor (VEGF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Iris Trial in Assiut (Immunohistochemistry analysis)

Not yet recruiting
  • Iris
  • Immunohistochemistry analysis
  • Assiut, Egypt
    Hassan Lotfy
Jul 29, 2022

Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

Recruiting
  • Macular Edema Due to Type 2 Diabetes Mellitus
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023

Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

Recruiting
  • Retinal Vein Occlusion
  • Aflibercept Ophthalmic
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Jan 5, 2022

Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

Recruiting
  • Refractory Angina Pectoris
  • +2 more
  • Copenhagen, Denmark
  • +1 more
Oct 19, 2022

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

Completed
Has Results
  • Uveitis
  • Cystoid Macular Edema
  • Winston-Salem, North Carolina
    Wake Forest University Eye Center
Mar 7, 2022

Following Intensive Anti-VEGF Therapy in Wet AMD

Completed
  • Age-Related Macular Degeneration
  • Budapest, Hungary
  • +1 more
Dec 28, 2022

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

    Recruiting
    • Age Related Macular Degeneration
    • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
    • Xuzhou, Jiangsu, China
      XuZhou Central Hospital
    Feb 7, 2022

    Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)

    Terminated
    • Uveitis
    • +3 more
    • intravitreal injection of Conbercept
    • Beijing, Beijing, China
      Peking Union Medical College Hospital (PUMCH)
    Oct 24, 2022

    Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

    Active, not recruiting
    • Diarrhea
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Utilization of Cabozantinib in Adult Advanced or Metastatic

    Withdrawn
    • Renal Cell Carcinoma
      • (no location specified)
      Dec 17, 2020

      Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

      Active, not recruiting
      • Recurrent Brain Neoplasm
      • Bevacizumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Maternal Serum Vascular Endothelial Growth Factor in Pregnant

      Recruiting
      • Foetal Growth Restriction
      • obstetric Ultrasound
      • serum Vascular Endothelial Growth Factor
      • Cairo, Egypt
        Nesreen Abdel Fattah Abdullah Shehata
      Jan 30, 2021

      Pre-eclampsia, Intra-uterine Growth Retardation Trial in Grenoble (blood sample and doppler Ultrasound of uterine arteries)

      Completed
      • Pre-eclampsia
      • Intra-uterine Growth Retardation
      • blood sample and doppler Ultrasound of uterine arteries
      • Grenoble, Isere, France
        Clinical investigation center of the Grenoble University Hospita
      Aug 27, 2021

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Completed
      Has Results
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +8 more
      • Bevacizumab
      • Irinotecan Sucrosofate
      • Chicago, Illinois
        Northwestern University
      Dec 21, 2022

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

      Recruiting
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bevacizumab
      • +4 more
      • Phoenix, Arizona
      • +2 more
      Jun 27, 2022

      Macular Disease Trial in Omaha

      Suspended
      • Macular Disease
        • Omaha, Nebraska
        • +1 more
        Sep 16, 2022

        Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

        Recruiting
        • Resectable Hepatocellular Carcinoma
        • +4 more
        • Atezolizumab
        • +2 more
        • Houston, Texas
        • +1 more
        Oct 12, 2022

        Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

        Not yet recruiting
        • Fallopian Tube Carcinosarcoma
        • +10 more
        • Bevacizumab
        • +4 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Dec 29, 2022

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

        Recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +5 more
        • Bevacizumab
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 13, 2022

        Exudative Age-related Macular Degeneration Trial (intravitreal injection)

        Completed
        • Exudative Age-related Macular Degeneration
        • intravitreal injection
        • (no location specified)
        Apr 19, 2022